Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
Toshihiro Kudo(Osaka University), Yasuo Hamamoto(Keio University), Ken Kato(National Cancer Centre Japan), Takashi Ura(Aichi Cancer Center), Takashi Kojima(National Cancer Centre Japan), Takahiro Tsushima(Shizuoka Cancer Center), Shuichi Hironaka(Chiba Cancer Center), Hiroki Hara(Saitama Cancer Center), Taroh Satoh(Osaka University), Satoru Iwasa(National Cancer Centre Japan), Kei Muro(Aichi Cancer Center), Hirofumi Yasui(Shizuoka Cancer Center), Keiko Minashi(Chiba Cancer Center), Kensei Yamaguchi(Japanese Foundation For Cancer Research), Atsushi Ohtsu(National Cancer Centre Japan), Yuichiro� Doki(Osaka University), Yuko Kitagawa(Keio University)
Cited by 381
Abstract
Related Papers
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al.|International Journal of Cancer|2014|29k